Thymosin Beta-4 — Research Evidence & Community Data
Also known as: Tβ4, full-length thymosin beta-4
Research & educational use only. This content is not medical advice. Consult a qualified healthcare professional before using any peptide compound.
What Is Thymosin Beta-4?
Thymosin beta-4 is a naturally occurring 43-amino-acid peptide central to actin regulation, cell migration, and tissue repair. Full-length thymosin beta-4 (distinct from the TB-500 fragment marketed in research-chemical channels) has been evaluated in early human clinical trials for indications such as dry eye and wound healing. It is not FDA-approved; evidence is a mix of early-phase human trials and extensive preclinical work.
Is Thymosin Beta-4 FDA Approved?
Thymosin Beta-4 is investigational. It is treated as a research compound in the United States with no approved human clinical applications.
What Does the Research Show?
As of 2026, there are 4 human randomized controlled trials with a combined 400 subjects, and 40 animal model studies. Early-phase human trials (for example dry eye and dermal wounds) plus extensive animal data. Efficacy is not yet established by large RCTs.
No linked evidence entries yet.
What Do Community Logs Show?
No community logs include Thymosin Beta-4 yet. Browse community logs →
How Is Thymosin Beta-4 Used in Research?
Mechanism of action. Sequestration of G-actin and promotion of cell migration, angiogenesis, and tissue repair.
Half-life. Estimated multi-hour half-life.
Storage. Lyophilized: store frozen. Reconstituted: refrigerate 2-8C.
Reconstitution. Reconstituted with bacteriostatic water for research handling. Math only - not dosing guidance. See the reconstitution calculator — a math tool only, not dosing guidance.
What Does Thymosin Beta-4's Evidence Tier Mean?
Thymosin Beta-4 is rated Tier 2 · Observational. Supported by human observational or clinical reports. Evidence tiers are a shorthand for how strong the human data is — Tier 1 reflects human randomized controlled trials, while lower tiers rest on observational, animal, or theoretical evidence. A higher tier means more confidence that observed effects are real and caused by the compound rather than by chance or bias. For how to weigh each tier, see our guide to understanding peptide evidence tiers.
How Do You Evaluate Thymosin Beta-4 Sourcing and Quality?
Because research-chemical Thymosin Beta-4 is unregulated, sourcing quality varies widely between sellers. Before trusting any supplier, check its reputation and enforcement history in the ranked list of trusted peptide sellers, and look for a batch-specific certificate of analysis (COA) showing third-party HPLC or LC-MS purity testing. Purity claims without a named lab, a batch number, and a method are marketing, not data. If you are reconstituting lyophilized material, the reconstitution calculator handles the arithmetic — it is a math tool only and not dosing guidance.
Where to Buy Thymosin Beta-4: Trusted & Verified Sellers
Thymosin Beta-4 is supplied by specialist research-chemical sellers rather than pharmacies, so where you buy it matters as much as what you buy. The sellers below have published moderator-approved third-party lab results for Thymosin Beta-4, ranked by overall reputation score. Always confirm a current batch-specific COA before purchasing.
No seller has published a lab result for Thymosin Beta-4 yet. Browse the ranked directory of trusted peptide sellers and check each one's lab testing and enforcement record before buying.
PeptidesHub does not sell Thymosin Beta-4 or facilitate transactions — this list is for research transparency only.
How Are Adverse Reactions to Thymosin Beta-4 Reported?
Structured adverse-event reports help the whole community spot safety signals early. You can browse approved reports on the adverse events page or submit one yourself. For a serious or life-threatening reaction, seek medical care and report it to FDA MedWatch.
Frequently Asked Questions
Thymosin Beta-4 is investigational. It is treated as a research compound in the United States.